title: Severe decrease in serum HDL-cholesterol during combination therapy of bezafibrate and pioglitazone.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Senba
authors.forename: Mikihiko
authors.initials: M
authors.lastname: Kawano
authors.forename: Masanobu
authors.initials: M
authors.lastname: Kawakami
mesh_terms: D001629:Bezafibrate / Q000009:adverse effects*; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D008076:Cholesterol, HDL; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone; D001629:Bezafibrate